Beneficial, but justifiable yet? ECCO2-Removal

C. Ates (Edirne, Turkey), F. Yilmaz (Edirne, Turkey), O. Mert (Edirne, Turkey), I. Kurt (Edirne, Turkey), H. Aggul (Edirne, Turkey), Z. Ademoglu (Edirne, Turkey), M. Reis (Edirne, Turkey), S. Efe (Edirne, Turkey), V. Inal (Edirne, Turkey)

Source: International Congress 2018 – Muscles and diaphragm, and quality improvement
Session: Muscles and diaphragm, and quality improvement
Session type: Thematic Poster
Number: 2344
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Ates (Edirne, Turkey), F. Yilmaz (Edirne, Turkey), O. Mert (Edirne, Turkey), I. Kurt (Edirne, Turkey), H. Aggul (Edirne, Turkey), Z. Ademoglu (Edirne, Turkey), M. Reis (Edirne, Turkey), S. Efe (Edirne, Turkey), V. Inal (Edirne, Turkey). Beneficial, but justifiable yet? ECCO2-Removal. 2344

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is at stake? What are the possible gains and risks?
Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Year: 2005


Positional therapy: who, when and how?
Source: Sleep and Breathing Conference 2021
Year: 2021


Does “UIPAF” really exist?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Long-term oral antibiotic treatment: why, what, when and to whom?
Source: Eur Respir Monogr 2017; 75: 185-205
Year: 2017


What we know and what we do not know about cannabis health effects: a concern for lung health?
Source: Virtual Congress 2020 – The changing and challenging landscape of the global tobacco epidemic: from vaping to cannabis?
Year: 2020

What’s new in neonatology?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018


Serotonergic antidepressants in COPD: beneficial or harmful?
Source: Eur Respir J, 52 (1) 1801095; 10.1183/13993003.01095-2018
Year: 2018



Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing?
Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019
Year: 2019



Steroids related tuberculosis: Does a subgroup require a more cautious approach?
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011

To tracheostomize or not to tracheostomize?
Source: Eur Respir J 2005; 26: Suppl. 49, 393s
Year: 2005

Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


Pathology: what do we actually want to know?
Source: Annual Congress 2008 - Multidisciplinary approach in interstitial lung disease
Year: 2008


What's new in the management of CAP?
Source: Annual Congress 2012 - New guidelines in respiratory infections
Year: 2012


Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018


CPAP holiday: are we there yet?
Source: Eur Respir J 2015; 45: 575-576
Year: 2015